Gains (losses) on other equity investments, net includes gains (losses) on our equity investments that were not accounted for under the equity method of accounting, and were as follows for the three years ended December 27, 2008:

Impairment charges for 2008 included a $176 million impairment charge recognized on our available-for-sale investment in the new Clearwire Corporation and $97 million of impairment charges on our investment in Micron (for information on the impairment of our equity method investment in Clearwire LLC, see "Note 6: Equity Method and Cost Method Investments"). The impairment charge on our investment in the new Clearwire Corporation was due to the fair value being significantly lower than the cost basis of our investment. The impairment charges on our investment in Micron reflect the difference between our cost basis and the fair value of our investment in Micron at the end of the second and third quarters of 2008, and were principally based on our assessment of Micron's financial results and the competitive environment, particularly for NAND flash memory products.